Since consumption of calorie dense palatable foods is highly pertinent to the onset and maintenance of obesity and diabetes, the potential modulation of taste sensitivity and food preference with GLP-1 based therapies is of important clinical relevance. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.